FDA Inspection 1195580 — Department of Defense - Naval Hospital Camp Pendleton

Department of Defense - Naval Hospital Camp Pendleton — FEI 2076574

The FDA completed an inspection of Department of Defense - Naval Hospital Camp Pendleton on January 23, 2023 in Camp Pendleton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 23, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Camp Pendleton, CA (United States)